CL2009001437A1 - Metodo para la preparacion de (1r, 2s, 3r)-1-(2-(isoxazol-3-il)-1h-imidazol-5-il)butano-1,2,3,4-tetraol utilizando isoxazol-3-carbonitrilo; y uno de los compuestos intermediarios considerados en la preparacion del isoxazol-3-carbonitrilo. - Google Patents
Metodo para la preparacion de (1r, 2s, 3r)-1-(2-(isoxazol-3-il)-1h-imidazol-5-il)butano-1,2,3,4-tetraol utilizando isoxazol-3-carbonitrilo; y uno de los compuestos intermediarios considerados en la preparacion del isoxazol-3-carbonitrilo.Info
- Publication number
- CL2009001437A1 CL2009001437A1 CL2009001437A CL2009001437A CL2009001437A1 CL 2009001437 A1 CL2009001437 A1 CL 2009001437A1 CL 2009001437 A CL2009001437 A CL 2009001437A CL 2009001437 A CL2009001437 A CL 2009001437A CL 2009001437 A1 CL2009001437 A1 CL 2009001437A1
- Authority
- CL
- Chile
- Prior art keywords
- isoxazol
- carbonitrile
- preparation
- tetraol
- isoxazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Método para preparar un compuesto derivado de 1-(2-heteroaril-1h-imidazol)-hidroxialquil de formula i, a partir de ciano-heteroarilo y 1-amino-3-hidroxialquil-2-ona, en condiciones suficientes para la formación del compuesto de formula i; compuesto intermediario.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7339908P | 2008-06-18 | 2008-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001437A1 true CL2009001437A1 (es) | 2010-08-20 |
Family
ID=41402541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001437A CL2009001437A1 (es) | 2008-06-18 | 2009-06-17 | Metodo para la preparacion de (1r, 2s, 3r)-1-(2-(isoxazol-3-il)-1h-imidazol-5-il)butano-1,2,3,4-tetraol utilizando isoxazol-3-carbonitrilo; y uno de los compuestos intermediarios considerados en la preparacion del isoxazol-3-carbonitrilo. |
Country Status (19)
Country | Link |
---|---|
US (1) | US7968726B2 (es) |
EP (1) | EP2318380B1 (es) |
JP (1) | JP2011524916A (es) |
KR (1) | KR20110019433A (es) |
CN (1) | CN102066344A (es) |
AR (1) | AR072152A1 (es) |
AU (1) | AU2009271409B2 (es) |
BR (1) | BRPI0914260A2 (es) |
CA (1) | CA2728097C (es) |
CL (1) | CL2009001437A1 (es) |
CO (1) | CO6341619A2 (es) |
ES (1) | ES2604313T3 (es) |
IL (1) | IL209817A0 (es) |
MX (1) | MX2010013817A (es) |
PE (1) | PE20100086A1 (es) |
RU (1) | RU2011101593A (es) |
TW (1) | TW201002698A (es) |
UY (1) | UY31899A (es) |
WO (1) | WO2010008734A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2011101535A (ru) * | 2008-06-18 | 2012-07-27 | Лексикон Фармасьютикалз, Инк. (Us) | Твердые формы (1r, 2s, 3r)-1-(2-изоксазол-3-ил)-1н-имидазол-4-ил)бутан-1, 2, 3, 4-тетраола и способы их применения |
WO2013049272A2 (en) | 2011-09-29 | 2013-04-04 | Theraceutix, Llc | Composition and method for treatment of symptoms associated with various skin conditions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4567194A (en) | 1983-03-10 | 1986-01-28 | The Coca-Cola Company | 2-Acylimidazole compounds, their synthesis and use as medicinal agents |
US4587194A (en) * | 1984-11-20 | 1986-05-06 | The Mead Corporation | Photosensitive material employing microcapsules having different photographic speeds |
AU2881797A (en) | 1996-05-31 | 1998-01-05 | University Of Wollongong, The | Acetyl derivatives of thiazoles and analogues |
AU2006261931A1 (en) * | 2005-06-28 | 2007-01-04 | Merck & Co., Inc. | Non-nucleoside reverse transcriptase inhibitors |
US7649098B2 (en) | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
TW200848029A (en) * | 2007-03-01 | 2008-12-16 | Lexicon Pharmaceuticals Inc | Heterocyclic compounds, compositions comprising them and methods of their use |
AR065980A1 (es) | 2007-04-12 | 2009-07-15 | Lexicon Pharmaceuticals Inc | Metodos para preparar compuestos basados en imidazol |
RU2011101535A (ru) | 2008-06-18 | 2012-07-27 | Лексикон Фармасьютикалз, Инк. (Us) | Твердые формы (1r, 2s, 3r)-1-(2-изоксазол-3-ил)-1н-имидазол-4-ил)бутан-1, 2, 3, 4-тетраола и способы их применения |
-
2009
- 2009-06-10 TW TW098119434A patent/TW201002698A/zh unknown
- 2009-06-16 CN CN2009801233909A patent/CN102066344A/zh active Pending
- 2009-06-16 RU RU2011101593/04A patent/RU2011101593A/ru unknown
- 2009-06-16 US US12/485,507 patent/US7968726B2/en active Active
- 2009-06-16 AR ARP090102171A patent/AR072152A1/es unknown
- 2009-06-16 AU AU2009271409A patent/AU2009271409B2/en active Active
- 2009-06-16 UY UY0001031899A patent/UY31899A/es not_active Application Discontinuation
- 2009-06-16 WO PCT/US2009/047495 patent/WO2010008734A2/en active Application Filing
- 2009-06-16 MX MX2010013817A patent/MX2010013817A/es not_active Application Discontinuation
- 2009-06-16 CA CA2728097A patent/CA2728097C/en active Active
- 2009-06-16 ES ES09744243.8T patent/ES2604313T3/es active Active
- 2009-06-16 KR KR1020117001153A patent/KR20110019433A/ko not_active Application Discontinuation
- 2009-06-16 BR BRPI0914260A patent/BRPI0914260A2/pt not_active Application Discontinuation
- 2009-06-16 JP JP2011514748A patent/JP2011524916A/ja active Pending
- 2009-06-16 EP EP09744243.8A patent/EP2318380B1/en active Active
- 2009-06-16 PE PE2009000872A patent/PE20100086A1/es not_active Application Discontinuation
- 2009-06-17 CL CL2009001437A patent/CL2009001437A1/es unknown
-
2010
- 2010-12-07 IL IL209817A patent/IL209817A0/en unknown
-
2011
- 2011-01-18 CO CO11004599A patent/CO6341619A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW201002698A (en) | 2010-01-16 |
AR072152A1 (es) | 2010-08-11 |
EP2318380B1 (en) | 2016-08-24 |
WO2010008734A2 (en) | 2010-01-21 |
EP2318380A2 (en) | 2011-05-11 |
JP2011524916A (ja) | 2011-09-08 |
MX2010013817A (es) | 2011-02-24 |
CA2728097A1 (en) | 2010-01-21 |
CN102066344A (zh) | 2011-05-18 |
RU2011101593A (ru) | 2012-07-27 |
ES2604313T3 (es) | 2017-03-06 |
US7968726B2 (en) | 2011-06-28 |
KR20110019433A (ko) | 2011-02-25 |
PE20100086A1 (es) | 2010-02-08 |
WO2010008734A3 (en) | 2010-03-11 |
IL209817A0 (en) | 2011-02-28 |
US20090318705A1 (en) | 2009-12-24 |
CA2728097C (en) | 2017-01-03 |
AU2009271409A1 (en) | 2010-01-21 |
AU2009271409B2 (en) | 2014-01-30 |
BRPI0914260A2 (pt) | 2015-11-03 |
UY31899A (es) | 2010-01-29 |
CO6341619A2 (es) | 2011-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ600207A (en) | Substituted 4-aminocyclohexane derivatives | |
EA201100875A1 (ru) | Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов | |
ECSP12011799A (es) | Compuestos de espiropiperidina y uso farmacéutico de los mismos | |
EA201070912A1 (ru) | Производные оксима в качестве ингибиторов hsp90 | |
EA200901563A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
CU24000B1 (es) | Un derivado 2-carboxamida-cicloamino-urea-tiazol-piridilo | |
EA201100992A1 (ru) | Карбазолкарбоксамидные соединения, применимые в качестве ингибиторов киназы | |
EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
DOP2012000139A (es) | Nuevos compuestos de espiropiperidina | |
UY34202A (es) | Compuestos fungicidas 2-(2-clor0-4-(4-cloro-fenoxi)-fenil]-1-(1,2,4]triazol-1-1l-etanol alquilo sustituidos | |
HRP20120129T1 (en) | Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists | |
CL2009000923A1 (es) | Compuestos derivados de 1-(aminoacetil)-n-(1-cicloalquil)pirrolidina-2-carboxamida sustituidas; composicion farmaceutica; utiles para tratar la hepatitis c. | |
CL2009001414A1 (es) | Procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-ona sin aislacion de compuestos intermediarios; util para la sintesis de ivabradina. | |
SV2011003916A (es) | Nuevas lactamas como inhibidores de beta secretasa | |
EA201270280A1 (ru) | Соединения пиримидина в качестве ингибиторов при лечении туберкулеза | |
CL2012000560A1 (es) | Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08). | |
EA201100920A1 (ru) | Новые гербициды | |
CL2011000138A1 (es) | Uso de compuestos acido 1-{4-[1-(4-ciclohexil-3-trifluoro-metil-benciloxiimino)-etil-2-etil-bencil}-azetidin-3-carboxilico para la preparacion de un medicamento para prevenir, inhibir o tratar una condicion inflamatoria seleccionada de polimiositis o dermatomiositis. | |
NO20081207L (no) | Isoquinolines as IGF-1R inhibitors | |
ECSP11011045A (es) | 1-(arilsulfonil)-4-(piperazin-1-il)-1h-benzimidazoles como ligandos de 5-hidroxitriptamina-6 | |
EA201100594A1 (ru) | Триазольные и имидазольные соединения, их применение, а также содержащие их средства | |
MX362371B (es) | Proceso para preparar 2-metoximetil-1,4-bencenodiamina y sales de esta. | |
UY31900A (es) | Formas solidas de ( 1r, 2s, 3r)-1-(2-(usoxazol-3-il)-1h-imidazol-4-il)butano-1, 2, 3, 4-tetraol y metodos de uso. | |
MX2010009926A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico. | |
CL2009001437A1 (es) | Metodo para la preparacion de (1r, 2s, 3r)-1-(2-(isoxazol-3-il)-1h-imidazol-5-il)butano-1,2,3,4-tetraol utilizando isoxazol-3-carbonitrilo; y uno de los compuestos intermediarios considerados en la preparacion del isoxazol-3-carbonitrilo. |